Results 41 to 50 of about 686,514 (182)

Seasonal Malaria Chemoprevention Coverage in Guinea in 2019 [PDF]

, 2020
SMC involves the administration of a treatment course of sulfadoxine-pyrimethamine plus amodiaquine once a month to children aged 3–59 months during the high risk period each year to prevent malaria. SMC over 4 months of the year was introduced in Guinea in 2015 in 6 prefectures, scaling up to 13 prefectures by 2018. The present survey was conducted at
Loua, Kovana Marcel, Milligan, Paul
openaire   +1 more source

Additional file 6 of Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020

, 2022
Additional file 6: Table S5.
Nicolas Voirin (145764), Nagham Khanafer (457071), Tchassama Tchadjobo (11761319), Muriel Rabilloud (291555), Anne Thomas (90885), Tinah Atcha-Oubou (11761316), Jean Iwaz (284564), Tchaa A. Bakai (11761313)   +7 more
core   +1 more source

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01 _E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention

BMJ Open, 2020
Introduction Seasonal malaria chemoprevention (SMC), with sulphadoxine–pyrimethamine plus amodiaquine (SP+AQ) is effective but does not provide complete protection against clinical malaria.
Ismaila Thera, Irene Kuepfer, Daniel Chandramohan, Alassane Dicko, Issaka Zongo, Issaka Sagara, Matthew Cairns, Modibo Diarra, Amadou Tapily, Djibrilla Issiaka, Koualy Sanogo, Almahamoudou Mahamar, Frederic Sompougdou, Serge Yerbanga, Paul Milligan, Halidou Tinto, Opokua Ofori-Anyinam, Jean-Bosco Ouedraogo, B Greenwood   +18 more
openaire   +3 more sources

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens. [PDF]

, 2015
BACKGROUND: The burden of malaria remains high for children in parts of Africa despite the use of insecticide-treated bed nets (ITNs). Chemoprevention has the potential of reducing the malaria burden; however, limited data exist on the efficacy and ...
Tamara Clark, Grant Dorsey, Achan, Jane, Dorsey, Grant, Mwangwa, Florence, Kapisi, James, Kamya, Moses, Seyi Soremekun, Moses Kamya, Bigira, Victor, Soremekun, Seyi, Florence Mwangwa, Clark, Tamara, Kinara, Stephen, James Kapisi, Victor Bigira, Stephen Kinara, Jane Achan   +17 more
core   +1 more source

Additional file 1 of Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso

, 2022
Additional file 1: Figure S1. Monthly trends of uncomplicated malaria incidence in health districts before and after SMC implementation among older age group (5–14 years old and 15 years and more). Figure S2. Monthly trends of severe malaria incidence in
Mady Ouédraogo (6062639), Yazoumé Yé (32191), Arnold Fottsoh Fokam (12513707), Vincent De Brouwere (685436), Fati Kirakoya-Samadoulougou (3531539)   +4 more
core   +1 more source

Additional file 2 of Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020

, 2022
Additional file 2: Table S1.
Nicolas Voirin (145764), Nagham Khanafer (457071), Tchassama Tchadjobo (11761319), Muriel Rabilloud (291555), Anne Thomas (90885), Tinah Atcha-Oubou (11761316), Jean Iwaz (284564), Tchaa A. Bakai (11761313)   +7 more
core   +1 more source

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo

Malaria Journal, 2023
Background Malaria is the leading cause of morbidity and mortality among infants and children under-five in sub-Saharan Africa. In the Sahel, seasonal malaria chemoprevention (SMC) is delivered door-to-door in monthly cycles.
Taiwo Ibinaiye, Olusola Oresanya, Chibuzo Oguoma, Adaeze Aidenagbon, Olabisi Ogunmola, Christian Rassi, Sol Richardson   +6 more
doaj   +1 more source

Additional file 3 of Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020

, 2022
Additional file 3: Table S2.
Nicolas Voirin (145764), Nagham Khanafer (457071), Tchassama Tchadjobo (11761319), Muriel Rabilloud (291555), Anne Thomas (90885), Tinah Atcha-Oubou (11761316), Jean Iwaz (284564), Tchaa A. Bakai (11761313)   +7 more
core   +1 more source

Additional file 4 of Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020

, 2022
Additional file 4: Table S3.
Nicolas Voirin (145764), Nagham Khanafer (457071), Tchassama Tchadjobo (11761319), Muriel Rabilloud (291555), Anne Thomas (90885), Tinah Atcha-Oubou (11761316), Jean Iwaz (284564), Tchaa A. Bakai (11761313)   +7 more
core   +1 more source

Seasonal Malaria Chemoprevention Implementation: Effect on Malaria Incidence and Immunity in a Context of Expansion of P. falciparum Resistant Genotypes with Potential Reduction of the Effectiveness in Sub-Saharan Africa

Infection and Drug Resistance, 2022
Séni Nikiema,1,2 Issiaka Soulama,1,3 Salif Sombié,1 André-Marie Tchouatieu,4 Samuel Sindie Sermé,5 Noëlie Béré Henry,5 Nicolas Ouedraogo,1 Nathalie Ouaré,1,6 Raissa Ily,1,6 Oumarou Ouédraogo,3 Dramane Zongo,3 Florencia Wendkuuni Djigma,2 Alfred B Tiono,1
Nikiema S, Soulama I, Sombié S, Tchouatieu AM, Sermé SS, Henry NB, Ouedraogo N, Ouaré N, Ily R, Ouédraogo O, Zongo D, Djigma FW, Tiono AB, Sirima SB, Simporé J   +14 more
doaj